Pérez CLA, Planas SNL, Aroche AR

Language: Spanish
References: 7
Page:
PDF size: 264.96 Kb.

ABSTRACT

SARSCov 2 disease (Covid-19) manifests with a broad spectrum of clinical presentation, ranging from asymptomatic disease to severe respiratory failure, myocardial injury, and death. As more patients recover from the acute stage, reports of cardiovascular manifestations such as: heart failure, arrhythmias, myocarditis, among others that could be considered as a disease sequel, increase. Existing reports of coronavirus myocarditis are scarce, but it appears that more heart damage occurs in patients affected by Covid-19 than by other coronaviruses. A 50-year-old patient is presented, with a history of Covid-19 diagnosed 23 days ago, who comes in due to palpitations. In the emergency room the exam revealed arrhythmic heart sounds and elevated heart rate, corroborating atrial fibrillation in the electrocardiogram with rapid ventricular response, accompanied by increased cardiac enzymes. He was diagnosed as Post Covid-19 myocarditis and was admitted to intensive care unit, antiarrhythmic and immunomodulatory treatment with Jusvinza was started.

REFERENCES

1. Gasecka A, Pruc M, Kukula K, Gilis – Malinowska N, Filipiak KJ, Jaguszewski MJ, Szarpak L. Post – COVID – 19 heart syndome. Cariol J. 2021 Mar 1. Doi: 10.5603/CJ.a2021.0028.Epub ahead of print.PMID:33645626. http://www.who.int/classifications/icd/revisión/en/[Links]

2. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020;58(7):1131-4.

3. Panel de control de coronavirus(COVIS-19 (OMS) [Internet]. Organización Mundial de la Salud [citado 5march 2021]; 2021. Disponible en: https://covid19.who.int.

4. Parte de cierre del día 4 de marzo a las 12 de la noche. [Internet]. Sitio oficial de gobierno del Ministerio de Salud Pública de Cuba. [citado 5 march 2021]; 2021. Disponible en: https://salud.msp.gob.cu

5. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. EurHeart J [Internet]. 2020 [En línea 16 Mar 2020]:ehaa190. Disponible en: https://doi.org/10.1093/eurheartj/ehaa190

6. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on ananalysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8.

7. Prasad A, Panhwar S, Hendel RC, Sheikh O, Mushtaq Z, Dollar F, Vinas A, Alraies C, Almonani A, Nguyen TH, Amione-Guerra J, Foster MT, Sisson C, Anderson A, George JC, Kutkut I, Guareña Castillas JA, Badin A. COVID-19 and the cardiovascular system: A review of current data, summary of best practices, outline of controversies, and ilustrative case reports. Am Heart J. 2020 Aug; 226:174-187.doi:10.1016/j.ahj.2020.06.009.Epub 2020 Jun 15. PMID: 32599258; PMCID: PMC7834076